ArticleFrontiers in genetics2022

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.

Shirong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.